Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use.

Critical care (London, England)

Volumn 12, Issue 5, 2008, Pages 233-

  Slama, Thomas G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ANIMAL; CLINICAL TRIAL; DRUG EFFECT; ECONOMICS; HUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; CARBAPENEMS; CLINICAL TRIALS AS TOPIC; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 68949199479     PISSN: None     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6994     Document Type: Review

References (96)